Glufosfamide Versus 5-FU in Second Line Metastatic Pancreatic Cancer

Clinical trial NCT01954992 · RECRUITING

Trial details

NCT number: NCT01954992
Sponsor: Eleison Pharmaceuticals LLC.
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Metastatic Pancreatic Adenocarcinoma

Start date: 2014-04-01
Primary completion: 2026-06-01
Enrollment: 480

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.